search

Active clinical trials for "Fibromyalgia"

Results 191-200 of 1010

A Phase 3 Study To Evaluate The Efficacy And Safety Of TNX-102 SL In Patients With Fibromyalgia...

Fibromyalgia

This is a Phase 3, randomized, parallel-group, double-blind, placebo-controlled, 14-week study designed to evaluate the efficacy and safety of TNX-102 SL 5.6 mg (2 x 2.8 mg tablets) taken daily at bedtime for the treatment of fibromyalgia.

Terminated4 enrollment criteria

Influence of Co-diagnosis of Chronic Fatigue Syndrome in Patients With Fibromyalgia.

FibromyalgiaChronic Fatigue Syndrome1 more

The purpose of this study is to evaluate differences in neuroimmunoendocrine response and quality of live in patients diagnosed with Fibromyalgia, with or without a co-diagnosis of Chronic Fatigue Syndrome.

Active6 enrollment criteria

Safety and Efficacy of Milnacipran in Pediatric Patients With Primary Fibromyalgia

Primary Fibromyalgia

The purpose of this study is to evaluate the safety, tolerability, efficacy, and pharmacokinetics of milnacipran in pediatric patients aged 13 to 17 years with primary fibromyalgia.

Terminated16 enrollment criteria

Repeat of: A Study to Evaluate Efficacy and Safety of Sublingual TNX-102 SL Tablet Taken at Bedtime...

FibromyalgiaMyofascial Pain Syndromes5 more

The present trial is designed to assess the safety and efficacy of TNX-102 SL 2.8 mg tablets, taken daily at bedtime after 12 weeks of treatment in patients with fibromyalgia. The use of low-dose sublingual formulation of cyclobenzaprine (TNX-102 SL) dosed nightly for fibromyalgia is supported by the results of TNX-CY-F202 Phase 2b study -- the results provide strong evidence that TNX-102 SL 2.8 mg dosed nightly results in beneficial effects upon pain, sleep and other FM symptomatology.

Terminated15 enrollment criteria

Low-level Laser Therapy in Patients With Chronic Fibromyalgia

Chronic Pain

The purpose of this study is to examine the use of low level therapeutic laser (LLLT) for its effects on pain, fatigue, and physical function in individuals with fibromyalgia.

Terminated13 enrollment criteria

Open Label Extension Study of [S,S]-Reboxetine in Patients With Fibromyalgia

Fibromyalgia

This is a study to investigate the long-term safety and effectiveness [S,S]-Reboxetine in relieving the symptoms of Fibromyalgia in patients.

Terminated7 enrollment criteria

Safety and Efficacy of AGN 203818 for Pain Associated With Fibromyalgia Syndrome

Fibromyalgia

This study will explore the safety and effectiveness of different doses of AGN 203818 in treating the pain associated with fibromyalgia syndrome. The study is being conducted in 2 parts. Part A enrolled 211 pts dosed with either 3, 20, 60 mg BID AGN 203818 or placebo over 4 week treatment duration. Part B will enroll 440 pts and dose with either 20, 100, 160 mg BID AGN 203818 or placebo over 12 week treatment duration.

Terminated4 enrollment criteria

A Study to Test the Effectiveness and Safety of Fremanezumab on Participants With Fibromyalgia

Fibromyalgia

The primary objective of the study is to estimate the treatment effect of fremanezumab administered subcutaneously (SC) in reducing pain in adult participants with fibromyalgia (FM). A secondary objective is to evaluate the effect of fremanezumab on other efficacy measures, including pain, quality of life, sleep, fatigue, improvement in health, physical functioning, and mood. Another secondary objective is to evaluate the safety and tolerability of fremanezumab administered SC in adult participants with FM. The total duration of participant participation in the study is planned to be 21 weeks, consisting of a screening period of up to 5 weeks (ranging from 17 to 35 days), and a double-blind treatment period of 16 weeks.

Terminated24 enrollment criteria

A Study to Evaluate Lu AG06466 in Participants With Fibromyalgia

Fibromyalgia

The purpose of this study is to find out the effect of Lu AG06466 on the body in participants with fibromyalgia by assessing pain levels, brain signal changes, and psychiatric (mental) assessments.

Terminated6 enrollment criteria

Propranolol for Treating Fibromyalgia Pain

Fibromyalgia Pain

The purpose of the study to evaluate the feasibility of using low dose propranolol for people with fibromyalgia.

Terminated31 enrollment criteria
1...192021...101

Need Help? Contact our team!


We'll reach out to this number within 24 hrs